| 1 |
35199933 | Dexmedetomidine inhibits the growth and metastasis of esophageal cancer cells by down-regulation of lncRNA MALAT1. | 2022 Jun |
2 |
| 2 |
33179100 | Dexmedetomidine attenuates sevoflurane‑induced neurocognitive impairment through α2‑adrenoceptors. | 2021 Jan |
1 |
| 3 |
33782744 | Dexmedetomidine alleviates cardiomyocyte apoptosis and cardiac dysfunction may be associated with inhibition of RhoA/ROCK pathway in mice with myocardial infarction. | 2021 Jul |
1 |
| 4 |
33821300 | Dexmedetomidine ameliorates lipopolysaccharide-induced acute lung injury by inhibiting the PI3K/Akt/FoxO1 signaling pathway. | 2021 Jun |
1 |
| 5 |
30856162 | Dexmedetomidine Attenuates Lung Injury by Promoting Mitochondrial Fission and Oxygen Consumption. | 2019 Mar 11 |
1 |
| 6 |
31030092 | Dexmedetomidine alleviated lipopolysaccharide/D-galactosamine-induced acute liver injury in mice. | 2019 Jul |
2 |
| 7 |
31682847 | The therapeutic effect of dexmedetomidine on protection from renal failure via inhibiting KDM5A in lipopolysaccharide-induced sepsis of mice. | 2019 Dec 15 |
1 |
| 8 |
29351316 | Dexmedetomidine reduces lipopolysaccharide induced neuroinflammation, sickness behavior, and anhedonia. | 2018 |
1 |
| 9 |
29566706 | Dexmedetomidine attenuates lung apoptosis induced by renal ischemia-reperfusion injury through α2AR/PI3K/Akt pathway. | 2018 Mar 23 |
1 |
| 10 |
27987330 | Protection of Dexmedetomidine Against Ischemia/Reperfusion-Induced Apoptotic Insults to Neuronal Cells Occurs Via an Intrinsic Mitochondria-Dependent Pathway. | 2017 Sep |
1 |
| 11 |
28224201 | Dexmedetomidine protects against cisplatin-induced acute kidney injury in mice through regulating apoptosis and inflammation. | 2017 May |
1 |
| 12 |
28784305 | Dexmedetomidine (DEX) protects against hepatic ischemia/reperfusion (I/R) injury by suppressing inflammation and oxidative stress in NLRC5 deficient mice. | 2017 Nov 18 |
1 |
| 13 |
26683659 | Neuroprotective Effects of Dexmedetomidine Against Hypoxia-Induced Nervous System Injury are Related to Inhibition of NF-κB/COX-2 Pathways. | 2016 Oct |
1 |